Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)
China · Delayed Price · Currency is CNY 38.85
+0.33 (0.86%)
At close: Feb 13, 2026
SHA:688197 Revenue
In the year 2025, Shouyao Holdings (Beijing) Co., LTD. had annual revenue of 8.67M CNY with 119.88% growth. Shouyao Holdings (Beijing) Co., LTD. had revenue of 6.67M in the quarter ending December 31, 2025, with 4,594.67% growth.
Revenue
8.67M
Revenue Growth
+119.88%
P/S Ratio
666.59
Revenue / Employee
n/a
Employees
172
Market Cap
5.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.67M | 4.73M | 119.88% |
| Dec 31, 2024 | 3.94M | -1.29M | -24.61% |
| Dec 31, 2023 | 5.23M | 3.40M | 186.18% |
| Dec 31, 2022 | 1.83M | -11.21M | -85.98% |
| Dec 31, 2021 | 13.03M | 6.01M | 85.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novogene | 2.17B |
| Wuhan Hvsen Biotechnology | 1.67B |
| Kexing Biopharm | 1.52B |
| Xiangxue Pharmaceutical | 1.47B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| PharmaResources (Shanghai) | 667.47M |
| Lifecome Biochemistry | 587.04M |